COLLABORATION AND LICENSE AGREEMENT by and between AERIE PHARMACEUTICALS IRELAND, LTD. and SANTEN PHARMACEUTICAL CO., LTD. Dated as of October 28, 2020Collaboration and License Agreement • February 26th, 2021 • Aerie Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This Collaboration and License Agreement (this “Agreement”) is entered into as of October 28, 2020 (the “Effective Date”) by and between Aerie Pharmaceuticals Ireland, Ltd., a company organized and existing under the laws of Ireland with its principal place of business at Athlone Business & Technology Park, Athlone, Co. Westmeath, N37 DW40, Ireland (“Aerie”), and Santen Pharmaceutical Co., Ltd., a company organized and existing under the laws of Japan with its principal place of business at 4-20 Ofuka-cho, Kita-ku, Osaka 530-8552, Japan (“Santen”). Aerie and Santen are each hereafter referred to individually as a “Party” and together as the “Parties”.
